Galderma Canada Inc. Release: First of Its Kind Rosacea Therapy Now Available in Canada

THORNHILL, ON, Feb. 27, 2013 /CNW/ - Galderma Canada Inc. today announced Apprilon™, an innovative, anti-inflammatory rosacea treatment, is now available for prescription in Canada. Apprilon (Doxycycline Modified-Release Capsule, 40 mg) is the first and only oral, once-daily therapy designed specifically to treat the bumps and pimples associated with rosacea, and does not cause complications associated with long-term antibiotic use.1,2,3